Ischemic Heart Disease Management

Epidemiology and Burden

• The American College of Cardiology notes that in the United States, approximately 1 in 3 adults has some form of cardiovascular disease, including more than 13 million with coronary artery disease and more than 9 million with angina pectoris 1
• The economic burden of cardiovascular disease is substantial, with direct and indirect costs reaching $156 billion in the US in 2008, as reported by the Annals of Internal Medicine 1

Risk Factors

• The American Heart Association suggests that smoking, hypertension, dyslipidemia, obesity, metabolic syndrome, and sedentary lifestyle are modifiable risk factors for ischemic heart disease 2
• Diabetes mellitus significantly increases the risk of ischemic heart disease, according to the American Diabetes Association 2
• Age is a strong determinant of survival, with family history of premature CAD also being a significant risk factor, as stated by the American College of Cardiology 3

Clinical Manifestations

• Typical angina is characterized by substernal chest discomfort, radiation to neck, jaw, epigastrium, or arms, precipitated by exertion or emotional stress, and relieved by rest or nitroglycerin, as described by the American Heart Association 3
• Atypical presentations are more common in women and elderly patients, and may include nausea, vomiting, midepigastric discomfort, or sharp chest pain, according to the American College of Cardiology 3

Diagnostic Approach

• The American College of Cardiology recommends resting 12-lead ECG for all patients with suspected ischemic heart disease 1
• Risk stratification is essential to determine the appropriate diagnostic pathway, with high-risk features requiring urgent evaluation, as stated by the Journal of the American College of Cardiology 7
• Noninvasive testing, such as exercise ECG testing, stress imaging tests, and coronary CT angiography, should be based on pretest probability, according to the American Heart Association 1

Treatment Strategies

• The American College of Cardiology recommends antiplatelet therapy, lipid-lowering therapy, and anti-ischemic medications as part of guideline-directed medical therapy for ischemic heart disease 9
• Revascularization strategies, including percutaneous coronary intervention and coronary artery bypass grafting, should be considered for patients with high-risk features or those who have failed medical therapy, as stated by the Journal of the American College of Cardiology 8

Prognosis

• The prognosis of ischemic heart disease varies based on the extent and severity of coronary disease, left ventricular function, presence of comorbidities, response to medical therapy, and revascularization status, according to the American Heart Association 4
• Risk assessment tools, including clinical parameters, exercise test results, imaging findings, and angiographic data, can help predict survival and future acute coronary syndrome events, as reported by the Journal of the American College of Cardiology 4